| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/09/2008 | CN101214273A Medicament for treating osteoarticular tuberculosis and osteomyelitis and preparation thereof |
| 07/09/2008 | CN101214254A New use of mangiferin compounds |
| 07/09/2008 | CN101214236A Soybean isoflavone micropills and preparation thereof |
| 07/09/2008 | CN100400640C Jinshe medicinal wine |
| 07/09/2008 | CN100400515C Isoquinoline derivatives and methods of use thereof |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/09/2008 | CN100400100C Methods for preventing or attenuating patthoangiogenic conditions |
| 07/09/2008 | CN100400095C Rubber plaster for treating insufficient cold type chronic gstroentertis and rheumatic arthritis and preparation thereof |
| 07/09/2008 | CN100400087C Bone-knitting pellet and its preparing method |
| 07/09/2008 | CN100400082C Pharmaceutical composition for treating acute gout and its extraction method |
| 07/09/2008 | CN100400071C Wuxiangteng medicated liquor |
| 07/09/2008 | CN100400068C Medicated liquor of Folium premnae puberulae |
| 07/09/2008 | CN100400067C Dianduanxiang medicated liquor |
| 07/09/2008 | CN100400063C Xiaolongguojiang medicated liquor |
| 07/09/2008 | CN100400058C Wuxiangxueteng medicated liquor |
| 07/09/2008 | CN100400057C Xunmagen medicated liquor |
| 07/09/2008 | CN100399935C Masticatable capsule and process for producing the same |
| 07/08/2008 | WO2008083353A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396836 Pyrimidine compound and medicinal composition thereof |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396823 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2710043A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2345364C Use of bisphosphonic acid derivatives for preparing a medicine for treating lameness |
| 07/08/2008 | CA2231509C Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 07/08/2008 | CA2198706C Methods for the treatment of inflammatory joint disease |
| 07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | WO2008079293A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | WO2008078837A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 07/03/2008 | WO2008078730A1 Preparation for transnasal application |
| 07/03/2008 | WO2008078588A1 Pharmaceutical agent and method for treatment or prevention of articular cartilage deformation |
| 07/03/2008 | WO2008077277A1 Process for preparation of spider lyophilizate and use in medicaments and functional foods |
| 07/03/2008 | WO2008077241A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 07/03/2008 | WO2008077201A1 Naphthalan oil-based composition |
| 07/03/2008 | WO2008077174A1 Use of natural zeolith for the treatment, prevention, or delay of the onset of bone diseases |
| 07/03/2008 | WO2008054594A3 Method for controlling angiogenesis in animals |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161424 Compositions and Methods for the Systemic Treatment of Arthritis |
| 07/03/2008 | US20080161365 Methylene Derivatives |
| 07/03/2008 | US20080161364 Enteric Medicinal Composition For Oral Use |
| 07/03/2008 | US20080161352 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161348 Use of pitavastatin or salt thereof to treat rheumatoid arthritis |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161290 Serine hydrolase inhibitors |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 07/03/2008 | US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 07/03/2008 | US20080161274 Compounds and methods for inhibition of bone loss |
| 07/03/2008 | US20080161262 Using oligonucleotide sequences specific to interleukin beta as blocking agents for treatment and prevention of juvenile idiopathic arthritis |
| 07/03/2008 | US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161231 Methods and compositions for promoting organ development |
| 07/03/2008 | US20080160119 Sesquiterpenoid Derivatives Having Adipocyte Differentiation Inhibitory Effect |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160035 Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160021 Antagonist antibody or fragment that binds to a specific polypeptide, used for the treatment of a degenerative cartilaginous disorder, including osteo-, rheumatoid and psoriatic arthritis |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080160005 Interleukin-6 suppressive agent |
| 07/03/2008 | US20080159995 Using mixture comprising antifibrotic agents and stem cell modulators to treat and prevent connective tissue disorders |
| 07/03/2008 | US20080159994 Using threee dimensionally encapsulated progenitor cell mixture as ttherapeutic tool in cartilage repair and reconstructive and cosmetic surgeries |
| 07/03/2008 | US20080159988 Materials and methods for treating or preventing oxalate-related disease |
| 07/03/2008 | US20080159976 Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
| 07/03/2008 | DE202008002953U1 Chinesische Kräuterrezepte zur Behandlung von Beschwerden des Bewegungsapparates bei Mensch und Tier Chinese Herbal Recipes for the treatment of musculoskeletal disorders in humans and animals |
| 07/03/2008 | CA2674557A1 2-substituted-6-heterocyclic pyrimidone derivatives |
| 07/03/2008 | CA2673678A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 07/03/2008 | CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | CA2673410A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/02/2008 | EP1939300A1 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/02/2008 | EP1938827A1 Novel inhibitor of vascular endothelial growth factor expression |
| 07/02/2008 | EP1938802A1 Interfering RNAs targeting pro-inflammatory cytokines |
| 07/02/2008 | EP1937680A2 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 07/02/2008 | EP1937363A2 Use of compounds comprising fatty acid entities |
| 07/02/2008 | EP1937362A2 Bisphosphonate formulation |
| 07/02/2008 | EP1937298A1 Use of lactoferrin fragments and hydrolysates |
| 07/02/2008 | EP1937254A2 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 07/02/2008 | EP1937251A2 Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor |
| 07/02/2008 | EP1937250A2 Ligustilide derivatives for the treatment of inflammatory disorders |
| 07/02/2008 | EP1825861A4 Anti-inflammatory extract and agent and method for the production thereof |
| 07/02/2008 | EP1635791B1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1471916B1 Treatment of rheumatoid arthritis using imatinib |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1419792B1 Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
| 07/02/2008 | EP1128838B1 Extracellular matrix containing gdf-5 for inducing or enhancing chondrogenesis |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | CN101212961A HMB compositions and uses thereof |